The Implications of the FDA’s Decision on Aducanumab: A Q&A With Dr. Stephen Salloway
As part of our BrainTalk series, Being Patient spoke with Dr. Stephen Salloway about the development of aducanumab and what the future holds for…
As part of our BrainTalk series, Being Patient spoke with Dr. Stephen Salloway about the development of aducanumab and what the future holds for…
In conversation with Being Patient leading up to the 2021 NIH Alzheimer’s Research Summit, University of Michigan assistant professor of neurology Dr. Lisa McGinley…
Pharmaceutical companies are making plans to leverage the emerging technology of quantum computing in hopes of accelerating the search for the next Alzheimer’s treatment….
A new book by Dr. Jason Karlawish shares largely untold stories the history of the Alzheimer’s crisis, discussing the science, missed opportunities, and reasons…
The ocean deep holds untapped potential when it comes to new therapies that could treat diseases like cancer and Alzheimer’s. But climate change and…
Scientists have been studying the impacts of THC, a chemical in marijuana, on Alzheimer’s symptoms; now, a new mouse study looks at marijuana’s other…
What if we think of Alzheimer’s not as one disease, but three separate ones, with overlapping symptoms? Researchers behind a new study say Alzheimer’s…